760254

544644

CORONA

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Corona Remedies Limited Share Price Today

CORONA REMEDIES LIMITED is currently trading at ₹1792.4, up by ₹41.8 from the previous close. During the latest trading session, the stock touched an intraday high of ₹2100.70 and a low of ₹1773.10. Over the past six months, CORONA REMEDIES LIMITED has delivered a return of 21.7%, while the stock has declined 3.82% in the last one month.

Corona Remedies Limited performance

Today’s low Today’s high
₹ 1773.10 ₹ 2100.70
₹ 1797.70
52 week low 52 week high
₹ 1336.60 ₹ 2100.70
₹ 1797.70
Open Price ₹ 1800.00
Prev. Close ₹ 1750.60
Volume (Shares) 359201.00
Total traded value ₹ 6457.35
Upper Circuit ₹ 2100.70
Lower Circuit ₹ 1400.50
info

Investment Returns

Over 1 Month -3.82% Over 3 Months 12.60% Over 6 Months 21.47% Over 1 Year 21.70%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Corona Remedies Limited fundamentals


  • Market cap (Cr) 11,029.00
  • P/E Ratio (TTM) 57.84
  • Beta 0.72
  • Book Value / share 121.97
  • Return on equity 27.45%
  • EPS (TTM) 32.63
  • Dividend yield 0.57%
  • Net profit/quarter (Cr) 45.05
info icon alternate text
  • Market cap (Cr) 11,002.70
  • P/E Ratio (TTM) 57.84
  • Beta 0.52
  • Book Value / share 121.97
  • Return on equity 27.45%
  • EPS (TTM) 32.63
  • Dividend yield 0.57%
  • Net profit/quarter (Cr) 45.05
info icon alternate text

Corona Remedies Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 353.09
Operating Expense 302.74
Net Profit 45.05
Net Profit Margin (%) 12.75
Earnings Per Share (EPS) 7.37
EBITDA 66.13
Effective Tax Rate (%) 17.27
Particulars DEC 2025 (Values in Cr)
Revenue 342.42
Operating Expense 270.37
Net Profit 41.25
Net Profit Margin (%) 12.04
Earnings Per Share (EPS) 6.74
EBITDA 66.30
Effective Tax Rate (%) 25.25
Particulars SEP 2025 (Values in Cr)
Revenue 361.13
Operating Expense 293.79
Net Profit 52.15
Net Profit Margin (%) 14.44
Earnings Per Share (EPS) 8.53
EBITDA 80.74
Effective Tax Rate (%) 25.08
Particulars JUN 2025 (Values in Cr)
Revenue 346.54
Operating Expense 287.67
Net Profit 46.40
Net Profit Margin (%) 13.38
Earnings Per Share (EPS) 7.59
EBITDA 71.80
Effective Tax Rate (%) 23.79
Particulars MAR 2025 (Values in Cr)
Revenue 293.69
Operating Expense 251.70
Net Profit 31.34
Net Profit Margin (%) 10.67
Earnings Per Share (EPS) 5.12
EBITDA 55.64
Effective Tax Rate (%) 27.78
Particulars MAR 2026 (Values in Cr)
Revenue 1403.18
Operating Expense 1154.58
Net Profit 184.85
Net Profit Margin (%) 13.17
Earnings Per Share (EPS) 30.22
EBITDA 284.99
Effective Tax Rate (%) 23.02
Particulars MAR 2025 (Values in Cr)
Revenue 1196.42
Operating Expense 1004.20
Net Profit 149.05
Net Profit Margin (%) 12.45
Earnings Per Share (EPS) 24.37
EBITDA 245.91
Effective Tax Rate (%) 24.77
Particulars MAR 2025 (Values in Cr)
Book Value / Share 99.14
ROE % 27.50
ROCE % 29.82
Total Debt to Total Equity 0.23
EBITDA Margin 20.59
Particulars MAR 2024 (Values in Cr)
Book Value / Share 78.55
ROE % 20.36
ROCE % 23.46
Total Debt to Total Equity 0.21
EBITDA Margin 15.89
Particulars MAR 2023 (Values in Cr)
Book Value / Share 66.80
ROE % 20.79
ROCE % 24.94
Total Debt to Total Equity 0.07
EBITDA Margin 15.30
Particulars MAR 2025 (Values in Cr)
Book Value / Share 99.04
ROE % 27.45
ROCE % 29.78
Total Debt to Total Equity 0.23
EBITDA Margin 20.55
Particulars MAR 2024 (Values in Cr)
Book Value / Share 78.51
ROE % 20.38
ROCE % 23.47
Total Debt to Total Equity 0.21
EBITDA Margin 15.89
Particulars MAR 2023 (Values in Cr)
Book Value / Share 66.70
ROE % 23.24
ROCE % 27.29
Total Debt to Total Equity 0.08
EBITDA Margin 15.27
Particulars MAR 2022 (Values in Cr)
Book Value / Share 62.86
ROE % -0.18
ROCE % 0.95
Total Debt to Total Equity 0.13
EBITDA Margin 3.93
Particulars MAR 2021 (Values in Cr)
Book Value / Share 727.91
ROE % 23.09
ROCE % 25.14
Total Debt to Total Equity 0.16
EBITDA Margin 19.15
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 69.27
Total Assets 929.86
Total Liabilities 929.86
Total Equity 606.34
Share Outstanding 6
Price to Book Ratio 0.00
Return on Assets (%) 16.07
Return on Capital (%) 22.34
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 69.90
Total Assets 830.57
Total Liabilities 830.57
Total Equity 480.40
Share Outstanding 6
Price to Book Ratio 0.00
Return on Assets (%) 10.89
Return on Capital (%) 14.73
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 76.69
Total Assets 595.02
Total Liabilities 595.02
Total Equity 408.52
Share Outstanding 6
Price to Book Ratio 0.00
Return on Assets (%) 14.27
Return on Capital (%) 20.67
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 69.27
Total Assets 929.24
Total Liabilities 929.24
Total Equity 605.72
Share Outstanding 6
Price to Book Ratio 0.00
Return on Assets (%) 16.03
Return on Capital (%) 22.3
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 69.90
Total Assets 830.34
Total Liabilities 830.34
Total Equity 480.17
Share Outstanding 6
Price to Book Ratio 0.00
Return on Assets (%) 10.89
Return on Capital (%) 14.73
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 76.69
Total Assets 594.79
Total Liabilities 594.79
Total Equity 408.29
Share Outstanding 6
Price to Book Ratio 0.00
Return on Assets (%) 14.24
Return on Capital (%) 20.63
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 100.97
Total Assets 511.36
Total Liabilities 511.36
Total Equity 320.90
Share Outstanding 5
Price to Book Ratio 0.00
Return on Assets (%) -0.07
Return on Capital (%) -0.11
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 39.55
Total Assets 396.31
Total Liabilities 396.31
Total Equity 269.15
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 14.98
Return on Capital (%) 19.01
Particulars MAR 2025 (Values in Cr)
Net Income 198.53
Cash from Operations 233.77
Cash from Investing -83.84
Cash from Financing -106.58
Net change in Cash 0.06
Free Cash Flow 325.41
Particulars MAR 2024 (Values in Cr)
Net Income 118.48
Cash from Operations 174.66
Cash from Investing -266.64
Cash from Financing 98.54
Net change in Cash -11.34
Free Cash Flow 461.00
Particulars MAR 2023 (Values in Cr)
Net Income 110.88
Cash from Operations 128.52
Cash from Investing -50.24
Cash from Financing -44.74
Net change in Cash 7.70
Free Cash Flow 223.27
Particulars MAR 2025 (Values in Cr)
Net Income 198.14
Cash from Operations 233.77
Cash from Investing -83.83
Cash from Financing -106.58
Net change in Cash 0.06
Free Cash Flow 325.42
Particulars MAR 2024 (Values in Cr)
Net Income 118.47
Cash from Operations 174.66
Cash from Investing -266.64
Cash from Financing 98.54
Net change in Cash -11.34
Free Cash Flow 461.00
Particulars MAR 2023 (Values in Cr)
Net Income 110.66
Cash from Operations 128.52
Cash from Investing -50.24
Cash from Financing -44.74
Net change in Cash 7.70
Free Cash Flow 223.28
Particulars MAR 2022 (Values in Cr)
Net Income -0.79
Cash from Operations 99.20
Cash from Investing -65.77
Cash from Financing -29.85
Net change in Cash 2.03
Free Cash Flow 133.20
Particulars MAR 2020 (Values in Cr)
Net Income 78.34
Cash from Operations 60.19
Cash from Investing -50.24
Cash from Financing 32.40
Net change in Cash 22.92
Free Cash Flow 60.19
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.34 13.36 1.56 247.83 23.12 38.85
BLISS GVS PHARMA LTD. 453.35 36.80 4.03 4808.06 118.35 462.70
CIPLA LTD 1372.75 29.13 3.22 110896.97 1165.55 1672.20
FERMENTA BIOTECH LIMITED 320.60 14.14 2.32 943.56 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.34 22.62 4.16 247.83 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 544.35 24.40 4.25 1573.75 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8499.70 111.01 24.34 21249.25 7630.00 10557.00
BLISS GVS PHARMA LTD. 453.35 48.91 4.16 4808.06 118.35 462.70

Corona Remedies Limited shareholding pattern

Holding
21.74%
68.99%
2.24%
7.01%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

Corona Remedies Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
1803.30 3.01 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 1733.30
  • 26 Days 1713.30
  • 10 Days 1726.80
  • 50 Days 1682.50
  • 12 Days 1725.10
  • 100 Days 1609.40
  • 20 Days 1719.00
  • 200 Days 1576.60
1745.40 PIVOT
First Support 1733.80 First Resistance 1762.20 Second Support 1717.00 Second Resistance 1773.80 Third Support 1705.40 Third Resistance 1790.60
RSI 55.78 ADX 40.75 MACD 11.75 Williams % R -36.11 Commodity Channel Index (CCI) 61.10
Date 2026-06-16 Week 11752.00 Same Day 4591.00 Month 15703.00
1 Year 0.73 3 Year 0.72
Over 1 Month
-3.82% down
Over 1 Year
21.70% down
Over 3 Months
12.60% down
Over 3 Years
0.00% down
Over 6 Months
21.47% down
Over 5 Years
0.00% down

Corona Remedies Limited Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
19 Jun 2026 10.0 Final 19 Jun 2026 Equity shares
Dividend date Dividend amount Dividend type Record date Instrument type
19 Jun 2026 10.0 Final 19 Jun 2026 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Corona Remedies Ltd?

Answer Field

Corona Remedies Ltd share price is for NSE ₹ 1,792.40 & for BSE ₹ 1,792.35 as on Jun 17 2026 03:30 PM.

What is the Market Cap of Corona Remedies Ltd Share?

Answer Field

The market cap of Corona Remedies Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 17 2026 03:30 PM.

What is the 52 Week High and Low of Corona Remedies Ltd?

Answer Field

The 52 Week High and Low of Corona Remedies Ltd for NSE is ₹ 2,100.70 and ₹ 1,336.60 and for BSE is ₹ 2,097.35 and ₹ 1,336.95.

What is 1 year return for Corona Remedies Ltd?

Answer Field

The 1 year returns on the stock has been 21.70%.

What is the P/E Ratio of Corona Remedies Ltd Share?

Answer Field

As on Jun 17 2026 03:30 PM the price-to-earnings (PE) ratio for Corona Remedies Ltd share is 57.84.

What is the PB ratio of Corona Remedies Ltd Share?

Answer Field

As on Jun 17 2026 03:30 PM, the price-to-book (PB) ratio for Corona Remedies Ltd share is 121.97.

How to Buy Corona Remedies Ltd Share?

Answer Field

You can trade in Corona Remedies Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Corona Remedies Ltd Share on Bajaj Broking App?

Answer Field

To buy Corona Remedies Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Corona Remedies Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|